STAAR SURGICAL CO — Director's Dealing 2021

Aug 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-08-12

Reporting Person: Gesten Samuel J (Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-12	Common Stock	M	6667	$16.15	Acquired	49250	Direct
2021-08-12	Common Stock	M	4495	$29.80	Acquired	53746	Direct
2021-08-12	Common Stock	M	11364	$35.98	Acquired	65110	Direct
2021-08-12	Common Stock	M	7156	$27.53	Acquired	72266	Direct
2021-08-12	Common Stock	S	29682	$134.71	Disposed	42583	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-12	Common Stock Options	$16.15	M	6667	Disposed	2028-03-14	Common Stock (6667)	Direct
2021-08-12	Common Stock Options	$29.80	M	4495	Disposed	2028-06-13	Common Stock (4495)	Direct
2021-08-12	Common Stock Options	$35.98	M	11364	Disposed	2029-03-13	Common Stock (11364)	Direct
2021-08-12	Common Stock Options	$27.53	M	7156	Disposed	2030-03-19	Common Stock (7156)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.58 to $137.35 inclusive.

F2: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.

F3: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.